Molecular templates, inc. announced that it has received $14.999994 million in funding from vertex pharmaceuticals incorporated

On december 3, 2019, molecular templates, inc. (nasdaqcm:mtem) closed the transaction.
VRTX Ratings Summary
VRTX Quant Ranking